MRK - MERCK Kommanditgesellschaft auf Aktien
XETRA
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Darmstadt,
Germany
Type: Equity
MRK price evolution
MRK
| (in millions $) | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 | 30 Jul 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5579 | $6841 | $8605 | $5660 |
| Short term investments | $40 | $252 | $168 | $718 |
| Net receivables | $12572 | $11704 | $11674 | $12338 |
| Inventory | $6510 | $6358 | $6131 | $5930 |
| Total current assets | $31445 | $32168 | $31954 | $29977 |
| Long term investments | $1158 | $1084 | $2636 | $2785 |
| Property, plant & equipment | $23045 | $24488 | $22526 | $22231 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $105849 | $106675 | $106727 | $104469 |
| Current liabilities | ||||
| Accounts payable | $5507 | $5094 | $4218 | $3905 |
| Deferred revenue | ||||
| Short long term debt | $3077 | $1657 | $887 | $2839 |
| Total current liabilities | $25099 | $25694 | $23094 | $23394 |
| Long term debt | $31142 | $33683 | $33972 | $34072 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $65425 | $69040 | $65427 | $65727 |
| Shareholders' equity | ||||
| Retained earnings | $56697 | $53895 | $57082 | $54198 |
| Other shareholder equity | -$5214 | -$5107 | -$4862 | -$4851 |
| Total shareholder equity | $40424 | $37635 | $41300 | $38742 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6841 | $12694 | $8096 | $1355 |
| Short term investments | $252 | $498 | $1 | |
| Net receivables | $11704 | $9450 | $9230 | $4278 |
| Inventory | $6358 | $5911 | $5953 | $3294 |
| Total current assets | $32168 | $35722 | $30266 | $9280 |
| Long term investments | $1084 | $1847 | $966 | $539 |
| Property, plant & equipment | $24488 | $22768 | $19279 | $6421 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $63824 | |||
| Total investments | ||||
| Total assets | $106675 | $109160 | $105694 | $41796 |
| Current liabilities | ||||
| Accounts payable | $5094 | $4264 | $4609 | $1095 |
| Deferred revenue | ||||
| Short long term debt | $1657 | $2227 | $2716 | $1228 |
| Total current liabilities | $25694 | $24239 | $23872 | $9231 |
| Long term debt | $33683 | $28745 | $30690 | $9458 |
| Total noncurrent liabilities | $38857 | |||
| Total debt | ||||
| Total liabilities | $69040 | $63169 | $67510 | $24779 |
| Shareholders' equity | ||||
| Retained earnings | $53895 | $61081 | $53696 | $14452 |
| Other shareholder equity | -$5107 | -$4768 | -$4429 | -$1885 |
| Total shareholder equity | $37635 | $46058 | $38257 | $16946 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jul 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $15775 | $14630 | $15962 | |
| Cost of revenue | $3424 | $3340 | $4231 | |
| Gross Profit | $12351 | $11290 | $11731 | |
| Operating activities | ||||
| Research & development | $3985 | $8838 | $3307 | |
| Selling, general & administrative | $2302 | $2751 | $2600 | |
| Total operating expenses | $9711 | $14929 | $10138 | |
| Operating income | $6064 | -$299 | $5824 | |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $903 | -$821 | $870 | |
| Interest expense | -$303 | -$317 | ||
| Net income | ||||
| Net income | $4762 | -$1226 | $4745 | |
| Income (for common shares) | $4762 | -$1226 | $4745 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $60115 | $59283 | $48704 | $17534 |
| Cost of revenue | $13897 | $17206 | $13501 | $6782 |
| Gross Profit | $46218 | $42077 | $35463 | $10752 |
| Operating activities | ||||
| Research & development | $29711 | $11843 | $11907 | $2262 |
| Selling, general & administrative | $10296 | $9669 | $9403 | $5295 |
| Total operating expenses | $53904 | $38718 | $34811 | $14455 |
| Operating income | $6211 | $20565 | $13893 | $3079 |
| Income from continuing operations | ||||
| EBIT | $3079 | |||
| Income tax expense | $1512 | $1918 | $1521 | $637 |
| Interest expense | -$962 | -$806 | -$328 | |
| Net income | ||||
| Net income | $365 | $14519 | $13049 | $1987 |
| Income (for common shares) | $365 | $14519 | $13049 | $1987 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | $4762 | -$1226 | $4745 | -$5975 |
| Operating activities | ||||
| Depreciation | $446 | $441 | $416 | $404 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $3090 | $246 | $7717 | $3704 |
| Investing activities | ||||
| Capital expenditures | -$861 | -$989 | -$902 | -$965 |
| Investments | ||||
| Total cash flows from investing | -$1376 | $53 | -$334 | -$11443 |
| Financing activities | ||||
| Dividends paid | -$1950 | -$1852 | -$1855 | -$1885 |
| Sale and purchase of stock | -$35 | -$387 | -$459 | -$256 |
| Net borrowings | -$751 | -$3 | -$1945 | $6133 |
| Total cash flows from financing | -$2814 | -$2245 | -$4269 | $3758 |
| Effect of exchange rate | -$83 | -$162 | -$85 | -$62 |
| Change in cash and equivalents | -$1238 | -$1760 | $2957 | -$4074 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $365 | $14519 | $13049 | $1987 |
| Operating activities | ||||
| Depreciation | $1688 | $1704 | $1487 | $1673 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $13006 | $19095 | $14109 | $3477 |
| Investing activities | ||||
| Capital expenditures | -$3863 | -$4388 | -$4448 | -$1413 |
| Investments | $62 | |||
| Total cash flows from investing | -$14083 | -$4960 | -$16555 | -$1340 |
| Financing activities | ||||
| Dividends paid | -$7445 | -$7012 | -$6610 | -$680 |
| Sale and purchase of stock | -$1221 | $384 | -$638 | |
| Net borrowings | $4184 | -$2251 | $1631 | -$835 |
| Total cash flows from financing | -$4810 | -$9119 | $2593 | -$1522 |
| Effect of exchange rate | -$370 | -$237 | -$297 | -$40 |
| Change in cash and equivalents | -$5864 | $4606 | $14 | $575 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 8.89% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.83 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.25 |
| Quick ratio | 0.99 |